Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections-Reference-Cited by-同舟云学术

Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections

Published:2023-09-22 Issue:9 Volume:6 Page:e2335148
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Thinggaard Benjamin Sommer¹²³,Pedersen Frederik¹²,Grauslund Jakob¹²,Stokholm Lonny¹³

Affiliation:

1. Department of Clinical Research, University of Southern Denmark, Odense

2. Department of Ophthalmology, Odense University Hospital, Odense, Denmark

3. Open Patient Data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark

Abstract

This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2809790/thinggaard_2023_ld_230183_1696433948.26214.pdf

Reference6 articles.

1. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration—a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems.;Finger;BMC Ophthalmol,2020

2. Age-related macular degeneration.;Mitchell;Lancet,2018

3. Global incidence, progression, and risk factors of age-related macular degeneration and projection of disease statistics in 30 years: a modeling study.;Wang;Gerontology,2022

4. Components of diabetes prevalence in Denmark 1996-2016 and future trends until 2030.;Carstensen;BMJ Open Diabetes Res Care,2020

5. Evidence-based Danish guidelines for screening of diabetic retinopathy.;Grauslund;Acta Ophthalmol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting quality of life in patients with neovascular age-related macular degeneration;AJO International;2024-10

2. Intraocular and extraocular manifestations of thyroid dysfunction in Danish patients – A Nationwide Study;Acta Ophthalmologica;2024-09

3. Real-World Efficacy of Intravitreal Faricimab for Diabetic Macular Edema: A Systematic Review;Journal of Personalized Medicine;2024-08-28

4. Risk of post‐injection endophthalmitis peaks within the first three injections of anti‐vascular endothelial growth factor therapy: A nationwide registry‐based study;Acta Ophthalmologica;2024-06-03

5. Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-28